Patents by Inventor Anthony John Coyle

Anthony John Coyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen Binding Molecules Targeting Interleukine-4 Receptor Subunit Alpha (IL-4Ra)
    Publication number: 20260008857
    Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that bind to IL-4 receptor subunit alpha (IL-4R?). The disclosure also provides, in various embodiments, fusion proteins comprising one or more of polypeptides, polynucleotides encoding polypeptides, vectors and host cells suitable for expressing polypeptides, and methods for treating inflammatory conditions (e.g., atopic dermatitis).
    Type: Application
    Filed: June 13, 2025
    Publication date: January 8, 2026
    Inventors: Antonios O. Aliprantis, Zachary Kohl Costello, Anthony John Coyle, Lana Dinic, Kristen Park Hopson, Ahmed Ismail, Brinda Monian, Ryan Terrell Phennicie, Alexis Hiram Ramos, Karin Alma Frieda Reif, Adam Reid Root
  • Interferon beta antibodies and uses thereof
    Patent number: 12448439
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
    Type: Grant
    Filed: November 16, 2023
    Date of Patent: October 21, 2025
    Assignees: PFIZER INC., The Brigham and Women's Hospital, Inc.
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • Antigen Binding Molecules Targeting Thymic Stromal Lymphopoietin (TSLP)
    Publication number: 20250109193
    Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that specifically bind to a thymic stromal lymphopoietin (TSLP) (e.g., a full-length human TSLP). The disclosure also provides, in various embodiments, fusion proteins comprising one or more of the polypeptides, polynucleotides encoding the polypeptides, vectors and host cells suitable for expressing the polypeptides, and methods for treating a TSLP-associated disease or condition.
    Type: Application
    Filed: September 4, 2024
    Publication date: April 3, 2025
    Inventors: Antonios O. Aliprantis, Zachary Kohl Costello, Anthony John Coyle, Kristen Park Hopson, Ryan Terrell Phennicie, Alexis Hiram Ramos, Adam Reid Root, Lana Dinic, Karin Alma Frieda Reif
  • Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
    Patent number: 12110324
    Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that specifically bind to a thymic stromal lymphopoietin (TSLP) (e.g., a full-length human TSLP). The disclosure also provides, in various embodiments, fusion proteins comprising one or more of the polypeptides, polynucleotides encoding the polypeptides, vectors and host cells suitable for expressing the polypeptides, and methods for treating a TSLP-associated disease or condition.
    Type: Grant
    Filed: July 21, 2023
    Date of Patent: October 8, 2024
    Assignee: Flagship Pioneering Innovations VI, LLC
    Inventors: Antonios O. Aliprantis, Zachary Kohl Costello, Anthony John Coyle, Kristen Park Hopson, Ryan Terrell Phennicie, Alexis Hiram Ramos, Adam Reid Root, Lana Dinic, Karin Alma Frieda Reif
  • INTERFERON BETA ANTIBODIES AND USES THEREOF
    Publication number: 20240174742
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
    Type: Application
    Filed: November 16, 2023
    Publication date: May 30, 2024
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • Antigen Binding Molecules Targeting Thymic Stromal Lymphopoietin (TSLP)
    Publication number: 20240034780
    Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that specifically bind to a thymic stromal lymphopoietin (TSLP) (e.g., a full-length human TSLP). The disclosure also provides, in various embodiments, fusion proteins comprising one or more of the polypeptides, polynucleotides encoding the polypeptides, vectors and host cells suitable for expressing the polypeptides, and methods for treating a TSLP-associated disease or condition.
    Type: Application
    Filed: July 21, 2023
    Publication date: February 1, 2024
    Inventors: Antonios O. Aliprantis, Zachary Kohl Costello, Anthony John Coyle, Kristen Park Hopson, Ryan Terrell Phennicie, Alexis Hiram Ramos, Adam Reid Root, Lana Dinic, Karin Alma Frieda Reif
  • Interferon beta antibodies and uses thereof
    Patent number: 11858986
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: January 2, 2024
    Assignees: Pfizer Inc., The Brigham And Women's Hospital, Inc.
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • INTERFERON BETA ANTIBODIES AND USES THEREOF
    Publication number: 20210163588
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
    Type: Application
    Filed: November 9, 2020
    Publication date: June 3, 2021
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • Interferon beta antibodies and uses thereof
    Patent number: 10829553
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: November 10, 2020
    Assignees: PFIZER INC., THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • INTERFERON BETA ANTIBODIES AND USES THEREOF
    Publication number: 20170313769
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.
    Type: Application
    Filed: April 28, 2017
    Publication date: November 2, 2017
    Applicants: PFIZER INC., THE BRIGHAM AND WOMEN?S HOSPITAL, INC.
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle